State Medicaid Formularies: Do They Increase Costs?

Commentary By

Derrick A. Max

Derrick Max is Vice President of Policy at the Jefferson Forum and may be reached at dmax@jeffersonforum.org

Derrick A. Max

Derrick Max is Vice President of Policy at the Jefferson Forum and may be reached at dmax@jeffersonforum.org

Stephen D. Haner

Steve Haner is the Senior Fellow for Energy and the Environment at the Jefferson Forum and may be reached at Steve@thomasjeffersoninst.org

Commentary By

Linda Gorman

In an effort to control the rising cost of Medicaid, states frequently create a “Preferred Drug List” or Formulary. These formularies usually prevent patients from obtaining newer (and more expensive) drugs. But the evidence suggests that treating prescription drugs as a stand-alone cost doesn’t work, and a recent study demonstrates that for every dollar spent on newer drugs, non-drug medical expenditures are cut by $7.20.

Share This Commentary

More on the Same Issue